Scientists at IIT-BHU have developed a cutting-edge technology to effectively evaluate the drug resistance of viruses. This breakthrough could revolutionize the way antiviral treatments are developed and administered. By utilizing monoclonal antibodies, the researchers have created a sophisticated method to assess the efficacy of various drugs against viral strains. This development holds promise for enhancing our ability to combat viral infections and improve patient outcomes. Stay tuned for more updates on this groundbreaking innovation from Varanasi News – Times of India.
Read more about this — here
